

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.17457841 |
| 2 | negative regulation of interleukin-12 production (GO:0032695) | 4.90662542 |
| 3 | definitive hemopoiesis (GO:0060216) | 4.86432519 |
| 4 | response to peptidoglycan (GO:0032494) | 4.74525254 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.72230317 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.72230317 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.60438641 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.60438641 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.60438641 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.60438641 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.60438641 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.60438641 |
| 13 | platelet dense granule organization (GO:0060155) | 4.29456287 |
| 14 | negative regulation of cell killing (GO:0031342) | 4.25444075 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.25444075 |
| 16 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.18513492 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 4.10862240 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 4.01977619 |
| 19 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.00123799 |
| 20 | lymph vessel development (GO:0001945) | 3.93840196 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.87462308 |
| 22 | response to interferon-alpha (GO:0035455) | 3.77051914 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.75414970 |
| 24 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.75313714 |
| 25 | germinal center formation (GO:0002467) | 3.74099402 |
| 26 | response to interferon-beta (GO:0035456) | 3.73857566 |
| 27 | detection of other organism (GO:0098543) | 3.72850663 |
| 28 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.71123362 |
| 29 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.52367774 |
| 30 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.49501615 |
| 31 | response to muramyl dipeptide (GO:0032495) | 3.49215132 |
| 32 | regulation of natural killer cell differentiation (GO:0032823) | 3.48419980 |
| 33 | detection of bacterium (GO:0016045) | 3.45560763 |
| 34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.45051345 |
| 35 | cellular extravasation (GO:0045123) | 3.43109437 |
| 36 | megakaryocyte development (GO:0035855) | 3.40451020 |
| 37 | blood coagulation, intrinsic pathway (GO:0007597) | 3.39843386 |
| 38 | alpha-linolenic acid metabolic process (GO:0036109) | 3.39186011 |
| 39 | detection of molecule of bacterial origin (GO:0032490) | 3.38810092 |
| 40 | ribosomal small subunit assembly (GO:0000028) | 3.37829086 |
| 41 | neutrophil activation (GO:0042119) | 3.31514566 |
| 42 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.31327219 |
| 43 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.30959500 |
| 44 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.30887403 |
| 45 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.30498712 |
| 46 | response to host immune response (GO:0052572) | 3.29918934 |
| 47 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.29918934 |
| 48 | granulocyte activation (GO:0036230) | 3.28503587 |
| 49 | macrophage activation (GO:0042116) | 3.28245666 |
| 50 | detection of external biotic stimulus (GO:0098581) | 3.26464111 |
| 51 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.23774271 |
| 52 | endosome to pigment granule transport (GO:0043485) | 3.20642837 |
| 53 | endosome to melanosome transport (GO:0035646) | 3.20642837 |
| 54 | regulation of antigen processing and presentation (GO:0002577) | 3.20424964 |
| 55 | positive regulation of antigen processing and presentation (GO:0002579) | 3.20252198 |
| 56 | blood vessel maturation (GO:0001955) | 3.19007721 |
| 57 | regulation of interferon-alpha production (GO:0032647) | 3.16357604 |
| 58 | B cell mediated immunity (GO:0019724) | 3.15956638 |
| 59 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.15876867 |
| 60 | regulation of mast cell degranulation (GO:0043304) | 3.13973813 |
| 61 | response to type I interferon (GO:0034340) | 3.09227450 |
| 62 | endothelial tube morphogenesis (GO:0061154) | 3.07380658 |
| 63 | morphogenesis of an endothelium (GO:0003159) | 3.07380658 |
| 64 | heparin metabolic process (GO:0030202) | 3.06749645 |
| 65 | heparin biosynthetic process (GO:0030210) | 3.06749645 |
| 66 | regulation of gamma-delta T cell activation (GO:0046643) | 3.06142198 |
| 67 | positive regulation of B cell differentiation (GO:0045579) | 3.05861933 |
| 68 | T-helper 1 type immune response (GO:0042088) | 3.04900058 |
| 69 | cellular response to type I interferon (GO:0071357) | 3.03756706 |
| 70 | type I interferon signaling pathway (GO:0060337) | 3.03756706 |
| 71 | endothelium development (GO:0003158) | 3.02757727 |
| 72 | microglial cell activation (GO:0001774) | 3.00083095 |
| 73 | NIK/NF-kappaB signaling (GO:0038061) | 2.98930434 |
| 74 | myeloid cell activation involved in immune response (GO:0002275) | 2.98268573 |
| 75 | valine metabolic process (GO:0006573) | 2.96109781 |
| 76 | detection of biotic stimulus (GO:0009595) | 2.93691755 |
| 77 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.92129920 |
| 78 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.90431436 |
| 79 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.90393246 |
| 80 | regulation of mast cell activation (GO:0033003) | 2.90349322 |
| 81 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.88576098 |
| 82 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.88481826 |
| 83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.87295805 |
| 84 | response to host (GO:0075136) | 2.87295805 |
| 85 | response to host defenses (GO:0052200) | 2.87295805 |
| 86 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.87090424 |
| 87 | L-phenylalanine metabolic process (GO:0006558) | 2.87090424 |
| 88 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.86513931 |
| 89 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.85060370 |
| 90 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.83573633 |
| 91 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.82519650 |
| 92 | negative regulation of interleukin-6 production (GO:0032715) | 2.78721722 |
| 93 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.78165312 |
| 94 | L-phenylalanine catabolic process (GO:0006559) | 2.78165312 |
| 95 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.78027226 |
| 96 | regulation of interleukin-12 production (GO:0032655) | 2.77927684 |
| 97 | protein carboxylation (GO:0018214) | 2.77690523 |
| 98 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.77690523 |
| 99 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.77648336 |
| 100 | leukocyte aggregation (GO:0070486) | 2.75859627 |
| 101 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.75854027 |
| 102 | defense response to protozoan (GO:0042832) | 2.75554256 |
| 103 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.75391893 |
| 104 | positive regulation of mast cell activation (GO:0033005) | 2.74696571 |
| 105 | negative regulation of innate immune response (GO:0045824) | 2.74021881 |
| 106 | negative regulation of fibrinolysis (GO:0051918) | 2.73806727 |
| 107 | complement activation, alternative pathway (GO:0006957) | 2.73350725 |
| 108 | regulation of triglyceride catabolic process (GO:0010896) | 2.73160728 |
| 109 | fatty acid transmembrane transport (GO:1902001) | 2.73028499 |
| 110 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.72503996 |
| 111 | myeloid dendritic cell differentiation (GO:0043011) | 2.72424300 |
| 112 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.71686995 |
| 113 | respiratory burst (GO:0045730) | 2.69893083 |
| 114 | negative regulation of T cell mediated immunity (GO:0002710) | 2.69245706 |
| 115 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.68149104 |
| 116 | secretory granule organization (GO:0033363) | 2.68144076 |
| 117 | positive regulation of interleukin-10 production (GO:0032733) | 2.67734579 |
| 118 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.67533016 |
| 119 | superoxide anion generation (GO:0042554) | 2.65467707 |
| 120 | myeloid leukocyte activation (GO:0002274) | 2.64854691 |
| 121 | regulation of cholesterol storage (GO:0010885) | 2.64012196 |
| 122 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.63755936 |
| 123 | venous blood vessel morphogenesis (GO:0048845) | 2.63573215 |
| 124 | positive regulation of type 2 immune response (GO:0002830) | 2.63331804 |
| 125 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.62852844 |
| 126 | response to protozoan (GO:0001562) | 2.62334612 |
| 127 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.61773299 |
| 128 | regulation of leukocyte degranulation (GO:0043300) | 2.61678236 |
| 129 | amino-acid betaine metabolic process (GO:0006577) | 2.61524382 |
| 130 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.60842525 |
| 131 | neutrophil chemotaxis (GO:0030593) | 2.60539287 |
| 132 | 2-oxoglutarate metabolic process (GO:0006103) | 2.60203804 |
| 133 | response to thyroid hormone (GO:0097066) | 2.59649695 |
| 134 | aromatic amino acid family catabolic process (GO:0009074) | 2.59500006 |
| 135 | fatty acid beta-oxidation (GO:0006635) | 2.58461927 |
| 136 | cellular response to interferon-gamma (GO:0071346) | 2.57383562 |
| 137 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.57352506 |
| 138 | arginine metabolic process (GO:0006525) | 2.56470038 |
| 139 | negative regulation of viral genome replication (GO:0045071) | 2.56343793 |
| 140 | carnitine metabolic process (GO:0009437) | 2.55822552 |
| 141 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.55511725 |
| 142 | positive regulation of mast cell degranulation (GO:0043306) | 2.55511725 |
| 143 | positive regulation of interferon-beta production (GO:0032728) | 2.55324333 |
| 144 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.55069581 |
| 145 | regulation of fibrinolysis (GO:0051917) | 2.54994754 |
| 146 | regulation of T cell tolerance induction (GO:0002664) | 2.54637445 |
| 147 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.54375456 |
| 148 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.54215454 |
| 149 | regulation of tolerance induction (GO:0002643) | 2.53879128 |
| 150 | kynurenine metabolic process (GO:0070189) | 2.53662275 |
| 151 | mitochondrial DNA replication (GO:0006264) | 2.53315424 |
| 152 | positive regulation of vasculogenesis (GO:2001214) | 2.53146560 |
| 153 | regulation of protein activation cascade (GO:2000257) | 2.52377698 |
| 154 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.51062268 |
| 155 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.50310542 |
| 156 | glyoxylate metabolic process (GO:0046487) | 2.49775292 |
| 157 | tryptophan catabolic process (GO:0006569) | 2.49566038 |
| 158 | indole-containing compound catabolic process (GO:0042436) | 2.49566038 |
| 159 | indolalkylamine catabolic process (GO:0046218) | 2.49566038 |
| 160 | positive regulation of blood coagulation (GO:0030194) | 2.49152343 |
| 161 | positive regulation of hemostasis (GO:1900048) | 2.49152343 |
| 162 | fatty acid oxidation (GO:0019395) | 2.47819533 |
| 163 | positive regulation of interferon-alpha production (GO:0032727) | 2.46214064 |
| 164 | carnitine shuttle (GO:0006853) | 2.46062570 |
| 165 | bile acid biosynthetic process (GO:0006699) | 2.45504413 |
| 166 | urate metabolic process (GO:0046415) | 2.45329234 |
| 167 | lymphangiogenesis (GO:0001946) | 2.45298259 |
| 168 | protein activation cascade (GO:0072376) | 2.45228259 |
| 169 | positive regulation of coagulation (GO:0050820) | 2.44413538 |
| 170 | lipid oxidation (GO:0034440) | 2.43529279 |
| 171 | negative regulation of viral entry into host cell (GO:0046597) | 2.42063482 |
| 172 | regulation of complement activation (GO:0030449) | 2.41399114 |
| 173 | mature B cell differentiation involved in immune response (GO:0002313) | 2.40190566 |
| 174 | myeloid dendritic cell activation (GO:0001773) | 2.39849655 |
| 175 | angiogenesis involved in wound healing (GO:0060055) | 2.39225366 |
| 176 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.39219802 |
| 177 | plasma lipoprotein particle clearance (GO:0034381) | 2.39090842 |
| 178 | immunoglobulin mediated immune response (GO:0016064) | 2.38910799 |
| 179 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.38656083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.50275506 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.04438421 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.41907669 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.29803557 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.99897799 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.56025308 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.27390955 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.15095719 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.87128462 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.84156624 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.76479919 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.75351686 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.71276605 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.67324185 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.57005410 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.56354310 |
| 17 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.51588370 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39760819 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.32966900 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27652425 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23567947 |
| 22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.17297211 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.16391049 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.12895219 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.09411193 |
| 26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.05383966 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04852861 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96519121 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.89581289 |
| 30 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.86521803 |
| 31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86413281 |
| 32 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.81889114 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.76485213 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.76141643 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75717154 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.75379291 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75107532 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72619928 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.69968547 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64805348 |
| 41 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.64273810 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64121584 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.62935970 |
| 44 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.60912008 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.58398252 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57201638 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.56808939 |
| 48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.54648367 |
| 49 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.54239915 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54021771 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.53763827 |
| 52 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.52460178 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51486598 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51450455 |
| 55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49840367 |
| 56 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.49642655 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.44683627 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.44588051 |
| 59 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41102667 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38172806 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37402426 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.37109756 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36231177 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31328847 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.31023818 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28554456 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27296755 |
| 68 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.26116920 |
| 69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26062462 |
| 70 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24424984 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21307037 |
| 72 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.20775547 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.20634049 |
| 74 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.18717279 |
| 75 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18188879 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16807747 |
| 77 | MYB_26560356_Chip-Seq_TH2_Human | 1.16657968 |
| 78 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15748262 |
| 79 | * MYB_26560356_Chip-Seq_TH1_Human | 1.15508135 |
| 80 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14913747 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14700098 |
| 82 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.12397976 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12218514 |
| 84 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10159005 |
| 85 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09339465 |
| 86 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09105226 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08854246 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08601843 |
| 89 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.07769818 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07582790 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07405054 |
| 92 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06074362 |
| 93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05613627 |
| 94 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.05515807 |
| 95 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04745923 |
| 96 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04403093 |
| 97 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03539675 |
| 98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03524616 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01920281 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01177852 |
| 101 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.99292912 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99277027 |
| 103 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97432704 |
| 104 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96974772 |
| 105 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95262449 |
| 106 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90573341 |
| 107 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90247158 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89343942 |
| 109 | MAF_26560356_Chip-Seq_TH2_Human | 0.89104538 |
| 110 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.88411646 |
| 111 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83891444 |
| 112 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.83566782 |
| 113 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83504214 |
| 114 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.81526151 |
| 115 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81454140 |
| 116 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81298059 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81229887 |
| 118 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80379991 |
| 119 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79451764 |
| 120 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.78649420 |
| 121 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.75603853 |
| 122 | P300_27268052_Chip-Seq_Bcells_Human | 0.74428391 |
| 123 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.73611893 |
| 124 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73008076 |
| 125 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.72462931 |
| 126 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72034889 |
| 127 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.71723838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 4.86775930 |
| 2 | MP0003724_increased_susceptibility_to | 3.59377798 |
| 3 | MP0001879_abnormal_lymphatic_vessel | 3.39838134 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 2.76181359 |
| 5 | MP0005167_abnormal_blood-brain_barrier | 2.66779918 |
| 6 | MP0005360_urolithiasis | 2.51552634 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.45831185 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.36637670 |
| 9 | MP0005365_abnormal_bile_salt | 2.24407362 |
| 10 | MP0006054_spinal_hemorrhage | 2.20350355 |
| 11 | MP0009785_altered_susceptibility_to | 2.19015086 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.17649621 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.15842610 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.03184009 |
| 15 | MP0004147_increased_porphyrin_level | 2.01734637 |
| 16 | MP0004510_myositis | 2.00559502 |
| 17 | MP0000465_gastrointestinal_hemorrhage | 2.00402587 |
| 18 | MP0009278_abnormal_bone_marrow | 1.93374580 |
| 19 | MP0004808_abnormal_hematopoietic_stem | 1.90059925 |
| 20 | MP0003436_decreased_susceptibility_to | 1.86145293 |
| 21 | MP0003828_pulmonary_edema | 1.81340424 |
| 22 | MP0000685_abnormal_immune_system | 1.81129547 |
| 23 | MP0005025_abnormal_response_to | 1.80882444 |
| 24 | MP0001545_abnormal_hematopoietic_system | 1.76507221 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 1.76507221 |
| 26 | MP0002396_abnormal_hematopoietic_system | 1.76322511 |
| 27 | MP0002405_respiratory_system_inflammati | 1.75599068 |
| 28 | MP0010329_abnormal_lipoprotein_level | 1.71586162 |
| 29 | MP0004130_abnormal_muscle_cell | 1.71363505 |
| 30 | MP0005671_abnormal_response_to | 1.68135774 |
| 31 | MP0002419_abnormal_innate_immunity | 1.66128160 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.65154534 |
| 33 | MP0009840_abnormal_foam_cell | 1.60192298 |
| 34 | MP0000343_altered_response_to | 1.58453342 |
| 35 | MP0004084_abnormal_cardiac_muscle | 1.53683727 |
| 36 | MP0003303_peritoneal_inflammation | 1.50741287 |
| 37 | MP0003252_abnormal_bile_duct | 1.43073986 |
| 38 | MP0008469_abnormal_protein_level | 1.42317457 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.39805581 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.37933136 |
| 41 | MP0004947_skin_inflammation | 1.37110919 |
| 42 | MP0009764_decreased_sensitivity_to | 1.37037878 |
| 43 | MP0002148_abnormal_hypersensitivity_rea | 1.36163487 |
| 44 | MP0001800_abnormal_humoral_immune | 1.36105987 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.35161980 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.33628109 |
| 47 | MP0001853_heart_inflammation | 1.32526359 |
| 48 | MP0002723_abnormal_immune_serum | 1.31307774 |
| 49 | MP0005083_abnormal_biliary_tract | 1.30711253 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.29377453 |
| 51 | MP0002332_abnormal_exercise_endurance | 1.28542142 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.28049707 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.27305256 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.25732466 |
| 55 | MP0003195_calcinosis | 1.21415954 |
| 56 | MP0005310_abnormal_salivary_gland | 1.21412534 |
| 57 | MP0005166_decreased_susceptibility_to | 1.20556324 |
| 58 | MP0000609_abnormal_liver_physiology | 1.19619882 |
| 59 | MP0000249_abnormal_blood_vessel | 1.19043518 |
| 60 | MP0009763_increased_sensitivity_to | 1.17212075 |
| 61 | MP0001819_abnormal_immune_cell | 1.16647194 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.16542077 |
| 63 | MP0002420_abnormal_adaptive_immunity | 1.16412054 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.16334135 |
| 65 | MP0001790_abnormal_immune_system | 1.15741978 |
| 66 | MP0005387_immune_system_phenotype | 1.15741978 |
| 67 | MP0003943_abnormal_hepatobiliary_system | 1.10120987 |
| 68 | MP0008004_abnormal_stomach_pH | 1.09967695 |
| 69 | MP0000598_abnormal_liver_morphology | 1.09832283 |
| 70 | MP0003448_altered_tumor_morphology | 1.09694526 |
| 71 | MP0000767_abnormal_smooth_muscle | 1.09639793 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 1.09492041 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.08599555 |
| 74 | MP0010630_abnormal_cardiac_muscle | 1.08233918 |
| 75 | MP0005385_cardiovascular_system_phenoty | 1.08196054 |
| 76 | MP0001544_abnormal_cardiovascular_syste | 1.08196054 |
| 77 | MP0006082_CNS_inflammation | 1.07917415 |
| 78 | MP0003763_abnormal_thymus_physiology | 1.07905351 |
| 79 | MP0000604_amyloidosis | 1.07644828 |
| 80 | MP0001873_stomach_inflammation | 1.06336148 |
| 81 | MP0002933_joint_inflammation | 1.05982319 |
| 82 | MP0002398_abnormal_bone_marrow | 1.05613397 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 1.04726943 |
| 84 | MP0003186_abnormal_redox_activity | 1.04560801 |
| 85 | MP0004036_abnormal_muscle_relaxation | 1.04409669 |
| 86 | MP0009697_abnormal_copulation | 1.04209883 |
| 87 | MP0002118_abnormal_lipid_homeostasis | 1.03863931 |
| 88 | MP0000689_abnormal_spleen_morphology | 1.03251626 |
| 89 | MP0005174_abnormal_tail_pigmentation | 1.03210714 |
| 90 | MP0004215_abnormal_myocardial_fiber | 1.03031997 |
| 91 | MP0003646_muscle_fatigue | 1.02612533 |
| 92 | MP0001663_abnormal_digestive_system | 1.02560858 |
| 93 | MP0001533_abnormal_skeleton_physiology | 1.01161704 |
| 94 | MP0005451_abnormal_body_composition | 1.00305399 |
| 95 | MP0003075_altered_response_to | 1.00287820 |
| 96 | MP0004272_abnormal_basement_membrane | 0.97833298 |
| 97 | MP0001851_eye_inflammation | 0.97783232 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 0.97534232 |
| 99 | MP0000716_abnormal_immune_system | 0.97293382 |
| 100 | MP0003866_abnormal_defecation | 0.95339794 |
| 101 | MP0002128_abnormal_blood_circulation | 0.95274815 |
| 102 | MP0002429_abnormal_blood_cell | 0.94916132 |
| 103 | MP0000858_altered_metastatic_potential | 0.94147341 |
| 104 | MP0008775_abnormal_heart_ventricle | 0.93034387 |
| 105 | MP0005164_abnormal_response_to | 0.91579114 |
| 106 | MP0005332_abnormal_amino_acid | 0.91534478 |
| 107 | MP0002254_reproductive_system_inflammat | 0.91339650 |
| 108 | MP0003690_abnormal_glial_cell | 0.91092243 |
| 109 | MP0002722_abnormal_immune_system | 0.90622768 |
| 110 | MP0009333_abnormal_splenocyte_physiolog | 0.87263984 |
| 111 | MP0005390_skeleton_phenotype | 0.87207131 |
| 112 | MP0003567_abnormal_fetal_cardiomyocyte | 0.86656267 |
| 113 | MP0005330_cardiomyopathy | 0.86638090 |
| 114 | MP0003279_aneurysm | 0.86412447 |
| 115 | MP0005595_abnormal_vascular_smooth | 0.85594259 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.85076444 |
| 117 | MP0005165_increased_susceptibility_to | 0.84145342 |
| 118 | MP0001666_abnormal_nutrient_absorption | 0.83227052 |
| 119 | MP0004883_abnormal_blood_vessel | 0.83111127 |
| 120 | MP0009643_abnormal_urine_homeostasis | 0.82905628 |
| 121 | MP0003566_abnormal_cell_adhesion | 0.82661988 |
| 122 | MP0005670_abnormal_white_adipose | 0.81918704 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.81640950 |
| 124 | MP0003183_abnormal_peptide_metabolism | 0.80382903 |
| 125 | MP0005535_abnormal_body_temperature | 0.78229176 |
| 126 | MP0003868_abnormal_feces_composition | 0.77814782 |
| 127 | MP0008260_abnormal_autophagy | 0.73526241 |
| 128 | MP0002132_abnormal_respiratory_system | 0.69948486 |
| 129 | MP0008874_decreased_physiological_sensi | 0.67812209 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.65867758 |
| 131 | MP0003045_fibrosis | 0.61132423 |
| 132 | MP0000703_abnormal_thymus_morphology | 0.60170929 |
| 133 | MP0004484_altered_response_of | 0.59894727 |
| 134 | MP0003795_abnormal_bone_structure | 0.53886623 |
| 135 | MP0005381_digestive/alimentary_phenotyp | 0.50579740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 4.80888632 |
| 2 | Spontaneous hematomas (HP:0007420) | 4.69576039 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.28011730 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.28011730 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.28011730 |
| 6 | Joint hemorrhage (HP:0005261) | 3.98227354 |
| 7 | Polycythemia (HP:0001901) | 3.81829115 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 3.79126511 |
| 9 | Deep venous thrombosis (HP:0002625) | 3.73640746 |
| 10 | Abnormality of the nasal mucosa (HP:0000433) | 3.73431177 |
| 11 | Obstructive lung disease (HP:0006536) | 3.70538954 |
| 12 | Chronic obstructive pulmonary disease (HP:0006510) | 3.70538954 |
| 13 | Prolonged bleeding time (HP:0003010) | 3.62489993 |
| 14 | Keratoconjunctivitis sicca (HP:0001097) | 3.59182375 |
| 15 | Epistaxis (HP:0000421) | 3.52999249 |
| 16 | Hematochezia (HP:0002573) | 3.51895640 |
| 17 | Facial diplegia (HP:0001349) | 3.51056749 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.45632916 |
| 19 | Thrombocytosis (HP:0001894) | 3.41118377 |
| 20 | Keratoconjunctivitis (HP:0001096) | 3.40715609 |
| 21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.39684611 |
| 22 | Abnormal platelet function (HP:0011869) | 3.38891059 |
| 23 | Impaired platelet aggregation (HP:0003540) | 3.38891059 |
| 24 | Vasculitis (HP:0002633) | 3.30518069 |
| 25 | Meningitis (HP:0001287) | 3.26958459 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.25327666 |
| 27 | Gingival bleeding (HP:0000225) | 3.16262529 |
| 28 | Pulmonary infiltrates (HP:0002113) | 3.15211233 |
| 29 | Encephalitis (HP:0002383) | 3.14517579 |
| 30 | Prolonged partial thromboplastin time (HP:0003645) | 3.14188790 |
| 31 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.13585616 |
| 32 | Myositis (HP:0100614) | 3.12466352 |
| 33 | Microcytic anemia (HP:0001935) | 3.08411328 |
| 34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.08045170 |
| 35 | Esophageal varix (HP:0002040) | 3.06480204 |
| 36 | Intrahepatic cholestasis (HP:0001406) | 3.04497197 |
| 37 | Increased IgE level (HP:0003212) | 2.99033606 |
| 38 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.98905466 |
| 39 | Dysostosis multiplex (HP:0000943) | 2.97542500 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.89592325 |
| 41 | Nonimmune hydrops fetalis (HP:0001790) | 2.89535576 |
| 42 | Menorrhagia (HP:0000132) | 2.88466624 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.82879772 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.82879772 |
| 45 | Thrombophlebitis (HP:0004418) | 2.80267107 |
| 46 | Orchitis (HP:0100796) | 2.77540189 |
| 47 | Abnormality of the intrinsic pathway (HP:0010989) | 2.75852603 |
| 48 | Xanthomatosis (HP:0000991) | 2.70074070 |
| 49 | Hyperlipoproteinemia (HP:0010980) | 2.68752154 |
| 50 | Loss of speech (HP:0002371) | 2.67766615 |
| 51 | Ragged-red muscle fibers (HP:0003200) | 2.67005619 |
| 52 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.65019378 |
| 53 | Pulmonary embolism (HP:0002204) | 2.64428087 |
| 54 | Urticaria (HP:0001025) | 2.64409907 |
| 55 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.63511910 |
| 56 | Purpura (HP:0000979) | 2.63490664 |
| 57 | Conjunctival telangiectasia (HP:0000524) | 2.62277196 |
| 58 | Gingivitis (HP:0000230) | 2.61203978 |
| 59 | Chronic otitis media (HP:0000389) | 2.60430232 |
| 60 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.59922228 |
| 61 | Recurrent bacterial skin infections (HP:0005406) | 2.58475018 |
| 62 | Recurrent abscess formation (HP:0002722) | 2.57498977 |
| 63 | Increased IgM level (HP:0003496) | 2.57168029 |
| 64 | Recurrent viral infections (HP:0004429) | 2.56050001 |
| 65 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.55949780 |
| 66 | Leukocytosis (HP:0001974) | 2.54977270 |
| 67 | Arterial thrombosis (HP:0004420) | 2.51695171 |
| 68 | Eczematoid dermatitis (HP:0000976) | 2.48045648 |
| 69 | Abnormality of the pleura (HP:0002103) | 2.47688775 |
| 70 | Hyperammonemia (HP:0001987) | 2.47033709 |
| 71 | Complement deficiency (HP:0004431) | 2.46374896 |
| 72 | Portal hypertension (HP:0001409) | 2.45360431 |
| 73 | Vertigo (HP:0002321) | 2.45321781 |
| 74 | Abnormality of the common coagulation pathway (HP:0010990) | 2.44442116 |
| 75 | Systemic lupus erythematosus (HP:0002725) | 2.43696732 |
| 76 | Cerebral hemorrhage (HP:0001342) | 2.42571234 |
| 77 | Episodic fever (HP:0001954) | 2.42471144 |
| 78 | Increased serum ferritin (HP:0003281) | 2.42366505 |
| 79 | Spontaneous abortion (HP:0005268) | 2.40843093 |
| 80 | Gangrene (HP:0100758) | 2.40790024 |
| 81 | Petechiae (HP:0000967) | 2.38943715 |
| 82 | Vacuolated lymphocytes (HP:0001922) | 2.37935983 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.35147694 |
| 84 | Disinhibition (HP:0000734) | 2.33913336 |
| 85 | Cellulitis (HP:0100658) | 2.32807445 |
| 86 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.32487590 |
| 87 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.32487590 |
| 88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.32487590 |
| 89 | Hypercholesterolemia (HP:0003124) | 2.30838123 |
| 90 | Increased cerebral lipofuscin (HP:0011813) | 2.30822301 |
| 91 | Abnormality of T cell number (HP:0011839) | 2.29865630 |
| 92 | Asymmetric septal hypertrophy (HP:0001670) | 2.28138962 |
| 93 | T lymphocytopenia (HP:0005403) | 2.26858425 |
| 94 | Hypergammaglobulinemia (HP:0010702) | 2.24458147 |
| 95 | Acne (HP:0001061) | 2.23795353 |
| 96 | Anorexia (HP:0002039) | 2.22534210 |
| 97 | Abnormality of the hepatic vasculature (HP:0006707) | 2.20342371 |
| 98 | Ketosis (HP:0001946) | 2.19723500 |
| 99 | Porencephaly (HP:0002132) | 2.16906529 |
| 100 | Mutism (HP:0002300) | 2.16738007 |
| 101 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.16050692 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 2.14278160 |
| 103 | Chest pain (HP:0100749) | 2.12500922 |
| 104 | Hemorrhage of the eye (HP:0011885) | 2.11434729 |
| 105 | IgM deficiency (HP:0002850) | 2.11366091 |
| 106 | Neoplasm of head and neck (HP:0012288) | 2.09756239 |
| 107 | Esophageal neoplasm (HP:0100751) | 2.09756239 |
| 108 | Nausea (HP:0002018) | 2.09716083 |
| 109 | Ventricular tachycardia (HP:0004756) | 2.08859977 |
| 110 | Hepatosplenomegaly (HP:0001433) | 2.08846027 |
| 111 | Pustule (HP:0200039) | 2.08139766 |
| 112 | Autoimmune hemolytic anemia (HP:0001890) | 2.07261299 |
| 113 | Hypoglycemic coma (HP:0001325) | 2.06521361 |
| 114 | Polyneuropathy (HP:0001271) | 2.06061563 |
| 115 | Abnormal number of erythroid precursors (HP:0012131) | 2.05144764 |
| 116 | Bruising susceptibility (HP:0000978) | 2.05133776 |
| 117 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.05130347 |
| 118 | Dicarboxylic aciduria (HP:0003215) | 2.05130347 |
| 119 | Inflammation of the large intestine (HP:0002037) | 2.05085054 |
| 120 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.03899102 |
| 121 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.03899102 |
| 122 | Abnormality of T cells (HP:0002843) | 2.03862043 |
| 123 | Mucopolysacchariduria (HP:0008155) | 2.03418178 |
| 124 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.03418178 |
| 125 | Hypertensive crisis (HP:0100735) | 2.03057550 |
| 126 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.00377701 |
| 127 | Glomerulonephritis (HP:0000099) | 2.00233305 |
| 128 | Panhypogammaglobulinemia (HP:0003139) | 1.99289008 |
| 129 | Progressive inability to walk (HP:0002505) | 1.99210082 |
| 130 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98913508 |
| 131 | Autoimmune thrombocytopenia (HP:0001973) | 1.98209747 |
| 132 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.98017070 |
| 133 | Interstitial pulmonary disease (HP:0006530) | 1.97993176 |
| 134 | Beaking of vertebral bodies (HP:0004568) | 1.97156219 |
| 135 | Lipoatrophy (HP:0100578) | 1.95179096 |
| 136 | Congenital, generalized hypertrichosis (HP:0004540) | 1.94694246 |
| 137 | Recurrent bronchitis (HP:0002837) | 1.94516623 |
| 138 | Hyperglycinuria (HP:0003108) | 1.93505737 |
| 139 | Gastrointestinal inflammation (HP:0004386) | 1.93478044 |
| 140 | Hypoalphalipoproteinemia (HP:0003233) | 1.92221412 |
| 141 | Myocardial infarction (HP:0001658) | 1.92158242 |
| 142 | Hemoptysis (HP:0002105) | 1.91705492 |
| 143 | Adactyly (HP:0009776) | 1.91261157 |
| 144 | Abnormality of the endocardium (HP:0004306) | 1.90573518 |
| 145 | Abnormality of macrophages (HP:0004311) | 1.90227470 |
| 146 | Atrioventricular block (HP:0001678) | 1.89238933 |
| 147 | Nasal polyposis (HP:0100582) | 1.88820118 |
| 148 | Amyloidosis (HP:0011034) | 1.88449746 |
| 149 | Hypobetalipoproteinemia (HP:0003563) | 1.88191672 |
| 150 | Albinism (HP:0001022) | 1.88162623 |
| 151 | Abnormal platelet volume (HP:0011876) | 1.87759384 |
| 152 | Aplastic anemia (HP:0001915) | 1.87431125 |
| 153 | Retrobulbar optic neuritis (HP:0100654) | 1.87180376 |
| 154 | Optic neuritis (HP:0100653) | 1.87180376 |
| 155 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.87013003 |
| 156 | Recurrent skin infections (HP:0001581) | 1.86249150 |
| 157 | Abnormality of complement system (HP:0005339) | 1.86011355 |
| 158 | Hypochromic anemia (HP:0001931) | 1.85442080 |
| 159 | Subaortic stenosis (HP:0001682) | 1.84277209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 7.06725148 |
| 2 | KDR | 5.50834950 |
| 3 | TGFBR2 | 3.52454059 |
| 4 | TGFBR1 | 3.23708375 |
| 5 | MAP2K3 | 2.93025993 |
| 6 | ERN1 | 2.69955147 |
| 7 | KIT | 2.53436136 |
| 8 | MAP4K1 | 2.51744732 |
| 9 | PKN2 | 1.96303266 |
| 10 | JAK3 | 1.84686885 |
| 11 | TBK1 | 1.79517855 |
| 12 | BCKDK | 1.72998135 |
| 13 | IRAK4 | 1.66734430 |
| 14 | TYK2 | 1.66034297 |
| 15 | IKBKE | 1.65113142 |
| 16 | MATK | 1.64662803 |
| 17 | FGR | 1.60341297 |
| 18 | MUSK | 1.59918444 |
| 19 | TNK2 | 1.53750196 |
| 20 | FLT3 | 1.48922362 |
| 21 | BTK | 1.45887271 |
| 22 | MAP3K14 | 1.45786113 |
| 23 | FGFR4 | 1.43097922 |
| 24 | TAOK1 | 1.39169988 |
| 25 | MYLK | 1.36519239 |
| 26 | TAOK2 | 1.30522851 |
| 27 | ZAP70 | 1.28506955 |
| 28 | MAP3K3 | 1.26069659 |
| 29 | DAPK2 | 1.23906901 |
| 30 | GRK7 | 1.23496090 |
| 31 | TRIB3 | 1.23251983 |
| 32 | TEC | 1.21928326 |
| 33 | PTK6 | 1.21796077 |
| 34 | EPHB1 | 1.18695092 |
| 35 | IRAK1 | 1.18400294 |
| 36 | EEF2K | 1.18271281 |
| 37 | CSF1R | 1.16231321 |
| 38 | JAK1 | 1.15149450 |
| 39 | IRAK3 | 1.14760326 |
| 40 | FGFR3 | 1.14425352 |
| 41 | ACVR1B | 1.13469666 |
| 42 | NME2 | 1.12585154 |
| 43 | GRK6 | 1.08124890 |
| 44 | RPS6KA4 | 1.06210149 |
| 45 | PRPF4B | 1.06073447 |
| 46 | PRKG2 | 1.04529451 |
| 47 | RIPK1 | 1.03916390 |
| 48 | BLK | 1.03160581 |
| 49 | MAP3K11 | 0.99184856 |
| 50 | SIK1 | 0.97354180 |
| 51 | MAP2K6 | 0.96639105 |
| 52 | IKBKB | 0.96238480 |
| 53 | GRK1 | 0.92534002 |
| 54 | ADRBK2 | 0.92293733 |
| 55 | CDC42BPA | 0.91390055 |
| 56 | ITK | 0.90368042 |
| 57 | TTN | 0.89633354 |
| 58 | CSK | 0.89498640 |
| 59 | TAOK3 | 0.87612949 |
| 60 | PAK4 | 0.86599357 |
| 61 | JAK2 | 0.84843823 |
| 62 | MAPK12 | 0.82510655 |
| 63 | BMPR2 | 0.81163025 |
| 64 | SYK | 0.80613303 |
| 65 | MAPKAPK3 | 0.80093789 |
| 66 | FES | 0.76456398 |
| 67 | RPS6KB2 | 0.74961764 |
| 68 | LRRK2 | 0.72103786 |
| 69 | MARK2 | 0.69935672 |
| 70 | CAMKK2 | 0.68795837 |
| 71 | MARK3 | 0.68169280 |
| 72 | PIK3CG | 0.67622520 |
| 73 | TXK | 0.66564897 |
| 74 | IRAK2 | 0.66556861 |
| 75 | RIPK4 | 0.64764813 |
| 76 | PTK2B | 0.64203735 |
| 77 | MAP3K13 | 0.63766782 |
| 78 | PRKAA2 | 0.62334340 |
| 79 | LCK | 0.62275932 |
| 80 | LYN | 0.61925054 |
| 81 | CHUK | 0.60210061 |
| 82 | HCK | 0.60042237 |
| 83 | FER | 0.59314206 |
| 84 | PRKCQ | 0.56141965 |
| 85 | DDR2 | 0.56062193 |
| 86 | NLK | 0.55872036 |
| 87 | MAP3K7 | 0.54428531 |
| 88 | TESK2 | 0.54050579 |
| 89 | MAP3K5 | 0.52785224 |
| 90 | MAP3K1 | 0.49793226 |
| 91 | SIK3 | 0.49509605 |
| 92 | MAPK4 | 0.49399651 |
| 93 | MOS | 0.48361962 |
| 94 | CAMK4 | 0.48342259 |
| 95 | MAPK11 | 0.47986742 |
| 96 | RET | 0.47687445 |
| 97 | EPHA3 | 0.47374024 |
| 98 | CDK19 | 0.46080877 |
| 99 | RPS6KL1 | 0.44495659 |
| 100 | RPS6KC1 | 0.44495659 |
| 101 | SIK2 | 0.43296843 |
| 102 | YES1 | 0.42833526 |
| 103 | MAP3K6 | 0.42510438 |
| 104 | PIK3CA | 0.42273597 |
| 105 | STK10 | 0.42251308 |
| 106 | TNIK | 0.41366661 |
| 107 | PIM1 | 0.41114385 |
| 108 | CDK6 | 0.40427119 |
| 109 | PDPK1 | 0.40134920 |
| 110 | MAPKAPK5 | 0.38952084 |
| 111 | CAMK1 | 0.38878632 |
| 112 | TRPM7 | 0.38819837 |
| 113 | PDK1 | 0.38376702 |
| 114 | FYN | 0.38044174 |
| 115 | STK4 | 0.37025834 |
| 116 | EGFR | 0.36800708 |
| 117 | PRKD2 | 0.36736633 |
| 118 | RPS6KA2 | 0.36688301 |
| 119 | INSRR | 0.36643272 |
| 120 | MAP3K10 | 0.36159091 |
| 121 | MAP3K12 | 0.35464433 |
| 122 | CDK4 | 0.34870643 |
| 123 | PINK1 | 0.34284606 |
| 124 | ABL2 | 0.33838797 |
| 125 | IGF1R | 0.32259524 |
| 126 | TLK1 | 0.32188357 |
| 127 | MAPK7 | 0.31640758 |
| 128 | PRKCH | 0.30812140 |
| 129 | PRKCD | 0.29594616 |
| 130 | RPS6KA6 | 0.29398411 |
| 131 | NEK9 | 0.29079352 |
| 132 | OBSCN | 0.28265050 |
| 133 | STK11 | 0.28138092 |
| 134 | PRKD1 | 0.27639060 |
| 135 | HIPK2 | 0.27235037 |
| 136 | DYRK1B | 0.24404311 |
| 137 | PIM2 | 0.24220343 |
| 138 | CDK8 | 0.23830708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.13535084 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.86643358 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.84677078 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.66907804 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.58483485 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53266873 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.49662951 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.43209695 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.38253748 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.37616245 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.18643243 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.16200476 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.07119611 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 2.02994548 |
| 15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.00016599 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.99136559 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.98601672 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.89588895 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.88236697 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.84319393 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74113617 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.72921830 |
| 23 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.68753535 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.66549508 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.62155829 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.62028549 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.61066169 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.57583803 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.55057464 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.53946302 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.50066248 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46285943 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.43882154 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38746897 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.36688168 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.36088626 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.35699299 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34040673 |
| 39 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.33513269 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.33295887 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30334963 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.28431599 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.25416031 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24621225 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.22462881 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21512434 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21269214 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.20560067 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.20435464 |
| 50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.20309382 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.18984835 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17881361 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 1.15048681 |
| 54 | Measles_Homo sapiens_hsa05162 | 1.12981640 |
| 55 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.11883504 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.09342275 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07537869 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07492865 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.04578653 |
| 60 | Ribosome_Homo sapiens_hsa03010 | 1.04063793 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01577942 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00679100 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.99572303 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98531960 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.98123090 |
| 66 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97580995 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97062060 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 0.95423353 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93483751 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93481426 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92363008 |
| 72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91996748 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89983010 |
| 74 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.88549966 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85919437 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.85908157 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85675728 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.84377093 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83869561 |
| 80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82911720 |
| 81 | Influenza A_Homo sapiens_hsa05164 | 0.82793869 |
| 82 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82632110 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82016076 |
| 84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.80853766 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79224137 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78423753 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78376080 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77909626 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77334684 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75847710 |
| 91 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.73240867 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70490590 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.69216076 |
| 94 | Shigellosis_Homo sapiens_hsa05131 | 0.68241390 |
| 95 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67666435 |
| 96 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67397672 |
| 97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67320553 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.66302274 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65497744 |
| 100 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.63577381 |
| 101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63124530 |
| 102 | Lysine degradation_Homo sapiens_hsa00310 | 0.62630669 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62352978 |
| 104 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60543086 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60050402 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59335633 |
| 107 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58895747 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57428469 |
| 109 | Salmonella infection_Homo sapiens_hsa05132 | 0.57241549 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55179884 |
| 111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.54158081 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54108496 |
| 113 | Tuberculosis_Homo sapiens_hsa05152 | 0.53393317 |
| 114 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.52646959 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51267368 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51266051 |
| 117 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48473893 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.47246137 |
| 119 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.47183114 |
| 120 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.47027878 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46484831 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | 0.46363248 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45861451 |
| 124 | Amoebiasis_Homo sapiens_hsa05146 | 0.44943731 |
| 125 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44847642 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44767277 |
| 127 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43624442 |
| 128 | Apoptosis_Homo sapiens_hsa04210 | 0.42469317 |
| 129 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39654836 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.39474620 |
| 131 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.39223016 |
| 132 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39033516 |
| 133 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38498839 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37493807 |
| 135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37301716 |
| 136 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36295478 |
| 137 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35943288 |
| 138 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34738775 |
| 139 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32345998 |
| 140 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32334255 |
| 141 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31046431 |
| 142 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28728310 |
| 143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28632632 |
| 144 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.27986351 |
| 145 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26167088 |
| 146 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26141243 |
| 147 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.24025993 |
| 148 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23449356 |
| 149 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23007866 |

